Plasmid DNA manufacturing technology - development of Boehringer Ingelheim with BIA Separations
Boehringer Ingelheim Austria and BIA Separations are both committed to leadership of manufacturing technology and innovation of biopharmaceuticals. The process developed is capable of producing pDNA on a large scale and at current Good Manufacturing Practice compliant levels for clinical and commercial application.
After the successful completion of the joint development the two companies are collaborating on a non-exclusive basis where BIA Separations will supply Boehringer Ingelheim Austria with CIM® columns.
Other news from the department research and development
Most read news
More news from our other portals
See the theme worlds for related content
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.